Literature DB >> 9933102

Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner.

S E Cotterell1, C R Engwerda, P M Kaye.   

Abstract

Control of Leishmania donovani infection in immunocompetent mice is associated with hepatic inflammation and granuloma formation, both of which are absent in severe combined immunodeficient (scid) mice. In both BALB/c and scid mice, L. donovani infection induced a rapid hepatic accumulation of mRNA encoding macrophage inflammatory protein-1alpha (MIP-(1alpha), monocyte chemoattractant protein-1 (MCP-1) and interferon-gamma inducible protein-10 (gammaIP-10). This response was not preceded by increased IL-4 production in either strain, unlike that reported in other infectious disease models. Interestingly, only gammaIP-10 mRNA was maintained at elevated levels throughout the first 7 days of infection, by mechanisms involving CD4+ and CD8+ T cells, and CD4+CD8+ cells not activated in scid mice. By in vivo depletion and reconstitution of scid mice it was demonstrated that T cells regulate the expression of all three chemokines studied, while they themselves only produce gammaIP-10 in appreciable quantities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933102     DOI: 10.1002/(SICI)1521-4141(199901)29:01<203::AID-IMMU203>3.0.CO;2-B

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation.

Authors:  H W Murray
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 2.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Leishmania donovani Lipophosphoglycan Increases Macrophage-Dependent Chemotaxis of CXCR6-Expressing Cells via CXCL16 Induction.

Authors:  Visnu Chaparro; Louis-Philippe Leroux; Aude Zimmermann; Armando Jardim; Brent Johnston; Albert Descoteaux; Maritza Jaramillo
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

4.  Changes of serum cytokine profiles in Korean vivax malarial patients after chemotherapy.

Authors:  T S Kim; Y B Chung; H J Choi; H J Yang
Journal:  Parasitol Res       Date:  2006-07-11       Impact factor: 2.289

5.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

6.  Fast high yield of pure Leishmania (Leishmania) infantum axenic amastigotes and their infectivity to mouse macrophages.

Authors:  Juliana Dias Costa; Renata Soares; Léa Cysne Finkelstein; Suzana Côrte-Real; Maria de Nazareth Meirelles; Renato Porrozzi
Journal:  Parasitol Res       Date:  2009-03-18       Impact factor: 2.289

7.  Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major.

Authors:  Simone Antoniazi; Helen P Price; Pascale Kropf; Marina A Freudenberg; Chris Galanos; Deborah F Smith; Ingrid Müller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors:  Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

9.  Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.

Authors:  Sanjay Varikuti; Gayathri Natarajan; Steve Oghumu; Rachel H Sperling; Ellen Moretti; James Stock; Tracey L Papenfuss; Abhay R Satoskar
Journal:  Cell Immunol       Date:  2016-09-06       Impact factor: 4.868

10.  Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.

Authors:  Henry W Murray; Elaine B Brooks; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.